Home › Idiopathic Pulmonary Fibrosis › Louisiana
Idiopathic Pulmonary Fibrosis clinical trials in Louisiana
4 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Louisiana.
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- LSU Health Shreveport, Shreveport
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Tulane Clinic, New Orleans
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 14, 2026 · NCT07671911Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Tulane University, New Orleans
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer site in Shreveport, LA, Shreveport
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.